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Persistent neuronal Ube3a 
expression in the suprachiasmatic 
nucleus of Angelman syndrome 
model mice
Kelly A. Jones1,2, Ji Eun Han1, Jason P. DeBruyne3 & Benjamin D. Philpot1,2
Mutations or deletions of the maternal allele of the UBE3A gene cause Angelman syndrome (AS), a 
severe neurodevelopmental disorder. The paternal UBE3A/Ube3a allele becomes epigenetically silenced 
in most neurons during postnatal development in humans and mice; hence, loss of the maternal 
allele largely eliminates neuronal expression of UBE3A protein. However, recent studies suggest that 
paternal Ube3a may escape silencing in certain neuron populations, allowing for persistent expression 
of paternal UBE3A protein. Here we extend evidence in AS model mice (Ube3am–/p+) of paternal UBE3A 
expression within the suprachiasmatic nucleus (SCN), the master circadian pacemaker. Paternal 
UBE3A-positive cells in the SCN show partial colocalization with the neuropeptide arginine vasopressin 
(AVP) and clock proteins (PER2 and BMAL1), supporting that paternal UBE3A expression in the SCN is 
often of neuronal origin. Paternal UBE3A also partially colocalizes with a marker of neural progenitors, 
SOX2, implying that relaxed or incomplete imprinting of paternal Ube3a reflects an overall immature 
molecular phenotype. Our findings highlight the complexity of Ube3a imprinting in the brain and 
illuminate a subpopulation of SCN neurons as a focal point for future studies aimed at understanding 
the mechanisms of Ube3a imprinting.
Mutations or deletions of the maternal allele of UBE3A cause Angelman syndrome (AS), a rare neurodevelop-
mental disorder characterized by developmental delay, lack of speech, seizures, motor abnormalities, happy affect, 
and sleep disturbances1. The UBE3A gene exhibits preferential expression from the maternal allele in a majority 
of neuronal subclasses, while its expression appears to be biallelic in other cell types2,3. Neuronal imprinting of 
UBE3A is achieved through paternal expression of an antisense transcript, UBE3A-ATS, which extends across 
the UBE3A gene and suppresses its expression in cis4,5. An early study in mice showed that expression of Ube3a is 
nearly exclusively maternal in neurons within the CA3 region of the hippocampus and in cerebellar Purkinje cells, 
with moderate maternal bias in the cerebral cortex6. Later work using a UBE3A-YFP (yellow fluorescent protein) 
fusion reporter mouse line demonstrated that Ube3a expression is preferentially maternal in neurons through-
out the cortex, hippocampus, cerebellum, and thalamus7. The maternal bias of UBE3A expression is established 
perinatally, and relaxed imprinting of Ube3a has been observed in early postnatal mouse visual cortex8 and 
cortical lysates9. Indeed, the paternal Ube3a allele is silenced in neurons in the mouse neocortex between birth 
and postnatal day 7 (P7), and at P7 granule cells in the dentate gyrus and cerebellum still exhibit paternal Ube3a 
expression10. These observations demonstrate a variable onset of imprinting across brain regions, likely related to 
differences in the timing of neuronal differentiation. While a clearer picture of parental Ube3a expression bias in 
many forebrain structures has begun to emerge, detailed knowledge of allelic contributions to Ube3a expression 
in the basal telencephalon, particularly the hypothalamus, is lacking.
Sleep disturbances in individuals with AS persist throughout childhood and manifest as reduced need for 
sleep, difficulties falling asleep, and sleep fragmentation11–13. Sleep disturbances in AS model mice (Ube3am–/p+), 
in which a null allele of Ube3a is maternally inherited, have also been consistently observed14,15. Because circadian 
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rhythms play a critical role in determining sleep onset, duration, and quality16, the possibility has been raised that 
disruptions in circadian rhythms might underlie the sleep disturbances observed in AS. UBE3A has been shown 
to interact with an important member of the molecular clock17,18, implicating it in the molecular mechanisms 
that drive circadian rhythmicity. We previously observed persistent expression of UBE3A in the suprachiasmatic 
nucleus (SCN) of the hypothalamus, the master circadian regulatory region in the mammalian brain, of AS model 
mice15, thus identifying a novel site for relaxation of maternal expression bias of Ube3a in the adult brain. Here 
we examine the expression patterns of UBE3A in the SCN of AS model mice and provide evidence for paternal 
expression of Ube3a in a subset of neurons in this circadian regulatory region. The persistence of paternal UBE3A 
may be important for SCN function and, together with other markers of young neurons, suggests a degree of 
neoteny in the molecular profile of adult SCN neurons.
Results
Characteristics of UBE3A immunofluorescence in the SCN of adult AS model mice. We 
previously made the surprising finding that UBE3A protein is expressed in the SCN of adult AS model mice15. To 
characterize the distribution of UBE3A expression throughout the SCN, we performed immunohistochemistry 
in coronal sections spanning the entire rostro-caudal extent of the SCN from wildtype (Ube3am+/p+), AS model 
(Ube3am–/p+), and homozygous null (Ube3am–/p–) mice. For these experiments we used a previously characterized 
antibody10,15 and an immunofluorescence approach optimized for sensitive detection of UBE3A10.
We observed strong UBE3A signal throughout the hypothalamus in wildtype mice that was absent in AS 
model mice, indicative of the specificity of the antibody (Fig. 1) and consistent with observations that the Ube3a 
mutant allele does not produce a detectable transcript or protein19. Notably, there was a subset of UBE3A-positive 
cells throughout the rostro-caudal extent of the SCN in AS model mice (Fig. 1), indicating persistent paternal 
Ube3a expression. This pattern was specific to the SCN, as regions immediately rostral or caudal to the SCN did 
not exhibit UBE3A that was readily apparent at this magnification (Fig. 1, topmost and bottommost panels). 
Moreover, while UBE3A expression patterns in the SCN and the nearby paraventricular nucleus (PVN) were 
comparable in wildtype mice (Fig. 2a), there was little UBE3A signal in the PVN compared to the SCN in AS 
model mice (Fig. 2b) and no detectable signal in homozygous null mice (Fig. 2c). Thus, paternal Ube3a expres-
sion is readily apparent in the SCN of AS model mice, but not in a similarly neuron-dense hypothalamic region.
Figure 1. UBE3A expression in the SCN of wildtype and AS model mice along the rostral-caudal axis. 
Representative confocal images of UBE3A immunofluorescence and DAPI counterstaining in rostral-to-caudal 
series of coronal sections through the SCN of wildtype (Ube3am+/p+), AS model (Ube3am–/p+), and homozygous 
null (Ube3am–/p–) mice. DAPI costaining demarcates SCN regions. UBE3A signal is detectable in Ube3am–/p+ 
sections containing the SCN but not in hypothalamic regions outside of the SCN, in regions rostral or caudal 
to the SCN (topmost or bottommost panels), or in sections from Ube3am–/p– mice. 3V, third ventricle; ox, optic 
chiasm. Scale bar, 100 μ m.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:28238 | DOI: 10.1038/srep28238
To provide additional evidence of persistent paternal Ube3a expression in the SCN, we employed a transgenic 
mouse line expressing a knockin allele in which yellow fluorescent protein (YFP) is fused to the carboxyl-terminus 
of UBE3A7. Maternal inheritance of this reporter allele (Ube3amYFP/p+) yielded UBE3A-YFP expression in virtu-
ally all neurons in the SCN and surrounding hypothalamus, including the PVN (Fig. 2d). Mirroring patterns of 
endogenous paternal UBE3A signal (Figs 1 and 2a–c), UBE3A-YFP expression in Ube3am+/pYFP mice was present 
in a subset of cells in the SCN, but paternal UBE3A-YFP expression was not detectable in surrounding hypotha-
lamic regions (Fig. 2e). As expected, UBE3A-YFP expression was absent in control littermate mice lacking the 
reporter allele (Ube3am+/p+) (Fig. 2f). Notably, while UBE3A-YFP signal in the SCN and PVN of Ube3amYFP/p+ 
Figure 2. Paternal UBE3A expression in the SCN but not the PVN in AS model mice. (a–c) Confocal 
micrographs of UBE3A immunofluorescence in hypothalamic regions surrounding the third ventricle 
in Ube3am+/p+ (a), Ube3am–/p+ (b), and Ube3am–/p– (c) mice. DAPI counterstaining demarcates SCN and 
PVN. High-magnification images show that UBE3A signal is observable in the SCN (solid boxes) and PVN 
(dashed boxes) of Ube3am+/p+ mice, as well as the SCN, but not the PVN, of Ube3am–/p+ mice. UBE3A signal 
is absent in the SCN and PVN of Ube3am–/p– mice (c) as expected. (d–f) YFP immunofluorescence and DAPI 
counterstaining in hypothalamic regions surrounding the third ventricle in Ube3amYFP/p+ (d), Ube3am+/pYFP (e), 
and Ube3am+/p+ (f) mice. High-magnification images of SCN (solid boxes) and PVN (dashed boxes) show that 
YFP signal is present in both the SCN and PVN of Ube3amYFP/p+ mice (d), but only in the SCN of Ube3am+/pYFP 
mice (e). YFP signal is absent in Ube3am+/p+ mice (f). 3V, third ventricle. Scale bars, 100 μ m (a,d, top); 25 μ m 
(a,d, bottom).
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mice was comparable, UBE3A-YFP signal in the PVN of Ube3am+/pYFP mice was dramatically reduced compared 
to the SCN (Fig. 2e). These data indicate that cells in the SCN express paternal UBE3A, while neurons in the PVN 
do not, and further confirm that the UBE3A immunofluorescent signal in the SCN of AS model mice reflects 
expression from the paternal allele.
Paternal UBE3A in the SCN colocalizes with SOX2, a marker of neuronal immaturity. Paternal 
Ube3a expression is a characteristic of glial cells, young or newly differentiated neurons, and postnatal neural stem 
cells10. Because many paternal UBE3A-positive cells in the SCN were large in diameter and lacked colocalization 
with the astrocytic marker GFAP (Supplementary Fig. S1), we hypothesized that they were neurons. To profile the 
relative maturity of putative neurons expressing paternal UBE3A in the SCN, we visualized UBE3A and NEUN 
immunofluorescent signals in the SCN of adult wildtype, AS model, and homozygous-null mice, along with SOX2 
(Fig. 3a,b). NEUN is a marker of mature neurons20,21; however, consistent with previous observations22–24, distri-
bution of NEUN immunofluorescence was heterogeneous in the SCN, with stronger expression in a central region 
and minimal expression in dorsal and medial regions (Fig. 3a,b). Paternal UBE3A-positive cells in AS model 
mice were largely negative for NEUN, as measured by cell counting (4.8% ± 0.76) (Fig. 3c). Similarly, only a small 
proportion of NEUN-positive neurons were also positive for paternal UBE3A (4.6% ± 1.4) (Fig. 3c). Higher reso-
lution imaging confirmed that most cells positive for either endogenous paternal UBE3A or paternal UBE3A-YFP 
did not express NEUN (Supplementary Fig. S2). These findings are concordant with previous work showing an 
inverse relationship between paternal Ube3a expression and NEUN expression during postnatal neuronal devel-
opment in the neocortex10. To provide complementary evidence for neuronal paternal UBE3A expression, we 
co-stained sections containing the SCN with NeuroTrace Fluorescent Nissl stain (Supplementary Fig. S3). Nissl 
staining could be observed throughout the SCN, while only a subset of Nissl-stained cells expressed NEUN in the 
SCN, as previously observed23. UBE3A immunofluorescence was localized to Nissl-stained cells, in SCN sections 
from both wildtype and AS model mice. In sections from AS model mice, 90.1 ± 0.776% of UBE3A-positive cells 
were also positive for Nissl stain (n = 3 mice, 2–3 sections per mouse, 88–176 cells per section).
We also employed other markers to determine the neuronal identity of paternal UBE3A-expressing cells. One 
such marker, SOX2 (sex-determining region Y [SRY]-related HMG box 2), is a member of the SOXB1 family of 
transcription factors and plays important roles in maintaining neural progenitors during development and in 
adult neural stem cell niches25,26. Surprisingly, Sox2 expression has been observed in neurons of the adult rodent 
SCN but not in other hypothalamic regions27, an unusual finding given Sox2’s role in maintaining neural stem 
cell populations. We hypothesized that SCN neurons expressing paternal UBE3A might also express SOX2, as 
both markers are strongly associated with neuronal immaturity. In contrast to NEUN, SOX2 expression was 
widespread across the SCN in all genotypes, similar to the pattern previously described27, and exhibited substan-
tial colocalization with UBE3A in the SCN of wildtype and AS model mice (Fig. 3a,b). In the SCN of AS model 
mice, nearly all paternal UBE3A-positive cells were also positive for SOX2 (97.2% ± 0.351), whereas a minority 
of SOX2-positive neurons were also positive for paternal UBE3A (18% ± 2.2) (Fig. 3d). As previously observed27, 
NEUN and SOX2 expression only partially overlapped, which is most apparent in the merged representative 
image for the homozygous null condition (Fig. 3b). Thus, in addition to SOX2 and perhaps other proteins, pater-
nal UBE3A comprises the molecular profile of immature neurons in the adult SCN.
Many neurons expressing paternal Ube3a in the SCN of AS model mice are AVP-positive. We 
next asked whether paternal UBE3A expression would overlap with one or more defined neuron populations in 
the SCN. Neuropeptide signaling is a key mechanism mediating intercellular communication among heteroge-
neous cell populations in the SCN neural circuit28. The neuropeptide arginine vasopressin (AVP) is synthesized 
and released from neurons in the SCN “shell”, which corresponds generally to the dorsomedial subdivision of 
the SCN29. We analyzed expression levels and the degree of colocalization of UBE3A and AVP in the SCN of 
wildtype and AS model mice sacrificed at zeitgeber time (ZT) 8 on a 12:12 light/dark (LD) cycle (Fig. 4a,b). 
Average intensity of AVP immunofluorescent signals across the SCN were not different between wildtype and 
AS model mice (wildtype, 230 ± 9.65 arbitrary units (a.u.); AS model, 245 ± 17.0 a.u.; p = 0.484, Student’s t test, 
n = 3) (Fig. 4c), illustrating that loss of maternal UBE3A does not impact AVP expression, either in cell bodies 
or neuronal processes. In the SCN of AS model mice, a subpopulation of AVP-positive neurons were positive for 
UBE3A (40% ± 4.4), as measured by cell counting, and a subpopulation of paternal UBE3A-positive neurons 
were also positive for AVP (29% ± 3.1) (Fig. 4d). While overlap with AVP-expressing neurons was moderate, 
paternal UBE3A expression was also present in cells outside of the dorsomedial regions of the SCN, as shown in 
lower-magnification images (Fig. 4a). These data suggest that paternal Ube3a expression in the SCN of AS model 
mice is not restricted to AVP-expressing neurons or the dorsomedial SCN.
Vasoactive intestinal peptide (VIP) is a neuropeptide that is critically important in the SCN for intercellular com-
munication from light-responsive “core” neurons to shell neurons, which receive minimal retinal input30. We exam-
ined VIP expression levels and colocalization with paternal UBE3A in the SCN of AS model mice (Fig. 4e,f). The 
average intensity of VIP immunofluorescent signal in the SCN was not different between wildtype and AS model 
mice sacrificed at ZT4 (wildtype, 299 ± 40.8 a.u.; AS model, 333 ± 36.2 a.u.; p = 0.568, Student’s t test, n = 3 mice) 
(Fig. 4g). While some VIP neurons were positive for paternal UBE3A (45% ± 5.7), only a small number of paternal 
UBE3A-positive neurons were also positive for VIP (7.5% ± 0.79) (Fig. 4h). Furthermore, cells expressing paternal 
UBE3A were found throughout the SCN beyond the ventral regions where VIP neurons are enriched (Fig. 4e).
Taken together, these findings show that loss of maternal Ube3a does not disrupt expression levels of either 
AVP or VIP across the SCN. Furthermore, our results reveal that UBE3A-positive neurons in AS model mice are 
more likely to express AVP than VIP in the SCN, but paternal Ube3a expression was not restricted to either of 
these SCN populations.
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Figure 3. Paternal UBE3A and SOX2 primarily colocalize in NEUN-negative cells in the SCN of AS 
model mice. (a,b) Representative confocal images of UBE3A, SOX2, and NEUN immunofluorescent signals 
in the SCN of Ube3am+/p+, Ube3am–/p+ and Ube3am–/p– mice. (b) High-magnification images of SCN regions in 
solid white boxes shown in a. UBE3A and SOX2 colocalize in many cells (arrows), which are largely distinct 
from NEUN-positive cells (double-headed arrows). (c) Quantification of colocalization between UBE3A and 
NEUN in the SCN of Ube3am–/p+ mice (UBE3A-positive cells positive for NEUN, n = 99–282 cells per section, 
3 sections each from 3 Ube3am–/p+ mice; NEUN-positive neurons positive for UBE3A, n = 125–376 cells per 
section, 3 sections each from 3 Ube3am–/p+ mice). (d) Quantification of colocalization between UBE3A and 
SOX2 in the SCN of Ube3am–/p+ mice (SOX2-positive cells positive for UBE3A, n = 386–1308 cells from 3 
sections each from 4 Ube3am–/p+ mice; UBE3A-positive cells positive for SOX2, n = 77–263 cells from 3 sections 
each from 4 Ube3am–/p+ mice). 3 V, third ventricle; ox, optic chiasm. Scale bars, 100 μ m (a); 25 μ m (b).
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Figure 4. Colocalization of UBE3A with AVP and VIP in the SCN of AS model mice. (a) Representative 
confocal images of immunofluorescent signals of UBE3A and AVP in coronal sections containing the SCN 
from Ube3am+/p+ and Ube3am–/p+ mice sacrificed at ZT8 on a 12:12 LD cycle. (b) High-magnification images 
of regions in white boxes in a. Arrows identify cells co-expressing UBE3A and AVP. (c) Quantification of 
average intensity of AVP immunofluorescence in SCN regions in Ube3am+/p+ and Ube3am–/p+ mice (p = 0.484, 
Student’s t test, n = 3 mice). (d) Quantification of AVP-UBE3A colocalization in the SCN of Ube3am–/p+mice 
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Paternal UBE3A-positive cells in the SCN express PER2 and BMAL1. Period homolog 2 (PER2) is 
a key component of the transcriptional-translational feedback loops that drive circadian rhythms in the SCN31 
and exhibits strong 24-hr expression rhythms in SCN neurons32. A recent study revealed lengthened circadian 
period using SCN tissue explants from AS model mice expressing the PmPer2::mPER2-LUC reporter17; however, 
we recently showed that rhythms in PER2 protein expression were not different between wildtype and AS model 
mice across a 12:12 light/dark cycle15. To address whether paternal UBE3A-positive neurons express PER2 and 
exhibit molecular rhythms, we examined colocalization of UBE3A and PER2 immunofluorescent signals in the 
SCN of wildtype and AS model mice sacrificed either at ZT0 (corresponding to lights-on, when PER2 levels are 
lowest) or ZT12 (lights-off, when PER2 levels are highest). AT ZT0, when PER2 expression was sparse, a subset 
of PER2-positive neurons also expressed paternal UBE3A in AS model mice (Fig. 5a,b). At ZT12, when PER2 
expression was widespread, most UBE3A-positive cells in the SCN of AS model mice strongly expressed PER2 
(Fig. 5c,d). PER2 immunofluorescent signals were not different between genotypes at either ZT0 or ZT12, as 
measured previously15. Thus, paternal Ube3a expression occurs in SCN neurons that participate in circadian 
timing.
BMAL1 is another central component of the transcriptional-translational feedback loops that comprise 
the molecular clock31. Recent work has implicated UBE3A in the regulation of BMAL1 stability. Activation of 
UBE3A in heterologous cells, induced by overexpression of the viral oncogenes E6/E7, increased ubiquitination 
of BMAL1, and UBE3A can interact with, ubiquitinate, and degrade BMAL118. A subsequent study showed that 
UBE3A interacts with BMAL1 in mouse brain, and that BMAL1 protein levels in the hypothalamus as detected 
by immunoblot were increased in AS mouse models compared with wildtype controls, providing evidence for 
a role for UBE3A in degrading BMAL1 in the brain17. We therefore examined whether paternal UBE3A expres-
sion overlapped with BMAL1 expression in the SCN (Fig. 6). BMAL1 immunofluorescence in the SCN at ZT0 
was high in the majority of neurons in both wildtype and AS model mice (Fig. 6a). Paternal UBE3A expression 
coincided with BMAL1 expression to a high degree; we rarely observed cells clearly expressing either protein 
alone (Fig. 6b). We also quantified the BMAL1 immunofluorescent signal in the SCN of wildtype, AS model, 
and homozygous-null mice sacrificed at ZT8 (a time when effects on BMAL1 stability should be readily appar-
ent due to low mRNA expression), and found no significant differences among genotypes (one-way ANOVA, 
F(2,10) = 0.4777, p = 0.6337, n = 4–5 mice) (Fig. 6c,d). Furthermore, when we examined BMAL1 levels across the 
day in the SCN of wildtype and AS model mice, we saw no difference in BMAL1 levels between genotypes at any 
time examined (Supplementary Fig. S4). However, Shi and colleagues reported that BMAL1 protein abundance 
in immunoblots of hypothalamus extracts were elevated in Ube3am–/p+ mice17. This apparent discrepancy sug-
gests that hypothalamic BMAL1 levels, outside the SCN, may be more drastically affected by UBE3A loss, per-
haps directly related to the persistent UBE3A only within the SCN. Taken together, our data show that paternal 
UBE3A-positive neurons in the SCN express BMAL1, and that maternal or even complete loss of Ube3a does not 
detectably perturb BMAL1 levels in the SCN.
Paternal Ube3a expression in the extended amygdala. SCN-dependent rhythms in PER2 protein 
expression have been observed in the bed nucleus of the stria terminalis (BNST)33 and the central nucleus of the 
amygdala (CeA)34, regions that are part of the extended amygdala, a limbic macrostructure of the forebrain. We 
wondered whether paternal Ube3a expression might be a more general feature of neurons that undergo rhythmic 
changes in gene expression in the adult brain. We examined paternal Ube3a expression in the BNST and CeA of 
adult UBE3A-YFP-expressing and AS model mice (Fig. 7). UBE3A-YFP expression was abundant in the BNST of 
Ube3amYFP/p+ mice, but not wildtype mice, as expected (Fig. 7a). Surprisingly, paternal UBE3A-YFP expression 
was detectable in a subset of BNST cells in Ube3am+/pYFP mice (Fig. 7a,b). Paternal UBE3A-YFP signal overlapped 
consistently with NEUN immunostaining (Fig. 7b), confirming that cells expressing paternal UBE3A-YFP in the 
adult BNST are mature neurons and demonstrating that paternal UBE3A can be expressed in neurons containing 
high levels of NEUN. Paternal expression of endogenous UBE3A in the BNST of AS model mice was qualita-
tively weaker than paternal UBE3A-YFP expression (compare Fig. 7a–d); however, paternal UBE3A signal was 
detectable in a subset of cells that co-expressed NEUN (Fig. 7d). In a similar fashion, paternal UBE3A-YFP was 
also expressed in a subset of NEUN-positive cells in the CeA, above the background fluorescence observed in 
wildtype sections (Fig. 7e,f), whereas paternal expression of endogenous UBE3A in CeA was much weaker (com-
pare Fig. 7e–h), present in a minor subset of cells that co-expressed NEUN (Fig. 7h). Thus, relaxation of Ube3a 
imprinting extends to more regions of the adult brain than previously appreciated and may be a common feature 
of neurons with pronounced circadian rhythmicity of gene expression.
(AVP-positive neurons positive for UBE3A, n = 28–149 cells from 3 sections each from 3 mice; UBE3A-positive 
neurons positive for AVP: n = 44–274 cells from 3 sections each from 3 mice). (e) Representative images of 
UBE3A and VIP immunofluorescent signals in coronal sections containing the SCN from Ube3am+/p+ and 
Ube3am–/p+ mice sacrificed at ZT4 on a 12:12 LD cycle. (f) High-magnification images of region in white boxes 
in e. Arrows identify cells co-expressing UBE3A and VIP; double-headed arrows indicate UBE3A-positive cells 
that lack VIP expression. (g) Quantification of average intensity of VIP immunofluorescence in SCN regions 
in Ube3am+/p+ and Ube3am–/p+ mice (p = 0.568, Student’s t test, n = 3 mice). (h) Quantification of VIP-UBE3A 
colocalization in the SCN of Ube3am–/p+ mice (VIP-positive neurons positive for UBE3A: n = 4–56 cells from 
1–3 sections each from 5 mice; UBE3A-positive neurons positive for VIP: n = 50–243 cells from 1–3 sections 
each from 5 mice). Scale bars, 100 μ m (a, e), 25 μ m (b,f).
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Discussion
In this study, we have established that paternal Ube3a expression occurs in neurons throughout the SCN in adult 
mice. Neurons expressing paternal Ube3a were also likely to express SOX2, a marker of newly differentiated 
neurons, and were less likely to express the mature neuronal marker NEUN. Despite having molecular charac-
teristics of immature neurons, paternal UBE3A-expressing neurons showed a time-of-day dependent change in 
PER2 levels, suggesting that they were functionally integrated into SCN circuitry. The BNST and CeA, regions of 
the extended amygdala that exhibit strong circadian rhythms of clock gene expression and control motivational 
behaviors, also exhibited paternal Ube3a expression in the adult. Our findings provide additional evidence for the 
persistence of markers of neuronal immaturity in the adult SCN, and highlight discrete groups of basal forebrain 
neurons in which paternal Ube3a appears to “escape” imprinting during postnatal development – knowledge that 
could be exploited to further elucidate molecular mechanisms of paternal Ube3a silencing.
Figure 5. Paternal UBE3A is expressed in PER2-positive neurons in the SCN. (a–d) Representative confocal 
micrographs of UBE3A and PER2 immunofluorescent signals in the SCN of Ube3am+/p+ and Ube3am–/p+ mice 
sacrificed at ZT0 (a,b) or ZT12 (c,d) on a 12:12 LD cycle. (b,d) High-magnification images of regions in white 
boxes in a and c respectively, showing colocalization of UBE3A with PER2 (arrows in b and d). Scale bars, 100 μ m 
(a,c), 25 μ m (b,d).
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We have provided evidence for the neuronal identity of paternal UBE3A-positive cells in the SCN. Paternal 
UBE3A expression exhibited substantial overlap with AVP, PER2, and BMAL1, proteins that are abundantly 
expressed in SCN neurons and are essential for SCN function and circadian rhythmicity. Due to its incomplete 
expression pattern in the SCN, the canonical neuronal marker NEUN was largely uninformative in defining the 
neuronal identity for paternal UBE3A-positive cells. Indeed, NEUN was expressed in SCN cells to the exclusion of 
paternal UBE3A and vice versa. Because previous observations suggest an inverse relationship between paternal 
UBE3A and NEUN expression in maturing neocortical neurons10, we speculate that regulation of these two genes 
is often coordinated.
It is possible that paternal UBE3A immunofluorescent signal observed in the SCN of AS model mice could 
be partially mediated by paternal UBE3A expression in glia, which biallelically express Ube3a10,35. Glia, particu-
larly astrocytes, are likely to play a variety of roles in SCN function, including the support of rhythmic changes 
in metabolism and intrinsic excitability of SCN neurons36. Immunofluorescence of the astrocytic marker GFAP 
exhibits circadian-dependent changes in the SCN37, and astrocytes exhibit intrinsic clock rhythmicity38. The ratio 
of astrocytes to neurons in the SCN is approximately 1:3, based on classifications of nuclei morphologies using 
electron microscopy39. In our study, GFAP immunofluorescence illustrated that only a minority of cells express-
ing paternal UBE3A are astrocytes; for example, in a digital zoom of a given region of the SCN accounts for only 
Figure 6. Paternal UBE3A is expressed in BMAL1-positive neurons in the SCN. (a,b) Representative 
confocal micrographs of UBE3A and BMAL1 immunofluorescent signals in the SCN of Ube3am+/p+ and 
Ube3am–/p+ mice sacrificed at ZT0 (lights-on) on a 12:12 LD cycle. (b) High-magnification images of regions 
in white boxes in a. UBE3A-positive cells in sections from Ube3am–/p+ mice also express BMAL1 (arrows in b). 
(c,d) BMAL1 immunofluorescence is similar in the SCN of Ube3am+/p+, Ube3am–/p+, and Ube3am–/p– mice (one-
way ANOVA, F(2,10) = 0.4777, p = 0.6337, n = 4–5 mice). UBE3A immunofluorescence is significantly decreased 
in Ube3am–/p+and Ube3am–/p– mice (one-way ANOVA, F(2,10) = 7.982, p = 0.0085, n = 4–5 mice; * p < 0.05,  
* * p < 0.01 compared to Ube3am+/p+). Symbols indicate mice of each genotype that were processed together 
and compared within each experiment. Representative images in c correspond to black diamonds in graphs (2 
Ube3am–/p+ mice from that cohort were included for quantification, and the representative Ube3am–/p+ image 
corresponds to the points with higher BMAL1 and UBE3A intensity values in each graph). Scale bars, 100 μ m 
(a,c), 25 μ m (b).
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3–4 cells, while paternal UBE3A is expressed in >10 cells in the same region (Supplementary Fig. S1). Thus the 
observed number of cells expressing detectable paternal UBE3A is higher than could be accounted for by astro-
cytes. Taken together with the co-expression of neuronal proteins such as PER2, BMAL1, and AVP, our analysis 
points to neurons as the major cell class contributing to the observed pattern of paternal UBE3A expression.
The persistence of paternal Ube3a expression, previously ascribed to immature neurons, constitutes further 
evidence of an immature molecular phenotype in adult SCN neurons. In addition to minimal NEUN expres-
sion23, SCN neurons express a number of genes generally thought to be important only during development. We 
observed a high density of SOX2-positive cells in the SCN, similar to a pattern previously described27, and nearly 
all paternal UBE3A-positive cells were positive for SOX2. Moreover, SOX3, a cofactor of SOX2, is also expressed 
in adult SCN, in addition to neurogenic niches such as the subgranular zone of the hippocampal dentate gyrus40. 
Doublecortin-like, a microtubule-associated protein critical for embryonic neurogenesis, is expressed in 
NEUN-negative SCN shell neurons, but not in the PVN or the surrounding hypothalamus24. Doublecortin-like 
is involved in cellular migration and structural reorganization, and thus its enrichment in the SCN may enable 
the high degree of plasticity that is thought to be required to support circadian rhythms41,42. Thus, convergent 
evidence suggests a degree of neoteny in the molecular profile of SCN neurons, which may have important impli-
cations for SCN circuit development and function.
Paternal UBE3A-positive neurons in the adult SCN bear a molecular resemblance to newly generated neurons, 
which have yet to integrate into surrounding circuitry. Although the details of adult neurogenesis in the SCN 
specifically are not well understood, neurogenesis occurs at constitutive but low levels in the adult mouse hypo-
thalamus43–45. However, paternal UBE3A is co-expressed by rhythmically PER2-expressing SCN neurons (Fig. 5), 
Figure 7. Paternal UBE3A expression in a subset of cells in the extended amygdala of AS model mice. (a–d) 
UBE3A expression in the BNST in Ube3amYFP/p+, Ube3am+/pYFP, and Ube3am+/p+ mice (a,b), and Ube3am+/p+, 
Ube3am–/p+, and Ube3am–/p– mice (c,d). In a, images encompassing the BNST from Ube3am+/pYFP and  
Ube3am+/p+ mice were adjusted for brightness and contrast independently from the Ube3amYFP/p+ image to make 
the background staining appreciable. (b,d) High-magnification images of paternal UBE3A-YFP (b) or paternal 
UBE3A (d) in boxed region in a and c, respectively. Arrows indicate cells co-expressing paternal UBE3A and 
NEUN; double-headed arrows in d indicate cells expressing UBE3A but not NEUN. (e–h) UBE3A expression in 
the CeA in sections from Ube3amYFP/p+, Ube3am+/pYFP, and Ube3am+/p+ mice (e,f), and Ube3am+/p+, Ube3am–/p+, 
and Ube3am–/p– mice (g,h). (f,h) High-magnification images of paternal UBE3A-YFP (f) or paternal UBE3A 
(h) in boxed region in e and g, respectively. Arrows indicate cells co-expressing paternal UBE3A and NEUN; 
double-headed arrows in h indicate cells expressing UBE3A but not NEUN. “Merge” images in d and h are 
overlays of UBE3A and NEUN channels. LV, lateral ventricle; ac, anterior commissure; ic, internal capsule; CPu, 
caudate putamen; LGP, lateral globus pallidus; ec, external capsule. Scale bars, 100 μ m (a,c,e,g), 25 μ m (b,d,f,h).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:28238 | DOI: 10.1038/srep28238
indicating that these neurons are not newly born, but rather are fully integrated into the surrounding oscillatory 
SCN network, despite their immature molecular phenotype.
In this study we provide evidence that SCN neurons maintain persistent expression of paternal UBE3A pro-
tein, revealing a relaxation of Ube3a imprinting in the SCN that is not typical of most neurons. It remains to be 
determined whether this feature of murine Ube3a expression is conserved in the human brain. Nevertheless, the 
identification of novel sites in the brain in which Ube3a imprinting is differentially regulated has broad impli-
cations. The most promising therapeutic strategies for AS take advantage of unsilencing of the paternal UBE3A 
allele46,47; neurons that exhibit differential parental Ube3a expression bias, such as those of the SCN, may allow 
inroads toward further understanding of the molecular mechanisms that regulate Ube3a imprinting, and thereby, 
the refinement of AS therapeutics.
Methods
Animals, Tissue Preparation and Immunofluorescence. All animal procedures were approved by the 
Institutional Animal Care and Use Committee of the University of North Carolina School of Medicine and were 
performed in accordance with the guidelines of the U.S. National Institutes of Health. AS model19 (Ube3am–/p+) 
(Jackson Labs Stock # 016590; C57BL6) mice and their wildtype littermates were generated by breeding 
Ube3am+/p– females with wildtype males. Experimental litters that included Ube3am–/p– mice were generated by 
breeding Ube3am+/p– females with Ube3am+/p– males. Experimental trios of Ube3aYFP mice7 (Jax Stock # 017765) 
were generated by breeding Ube3am+/pYFP females to Ube3am+/pYFP males, yielding Ube3am+/p+, Ube3amYFP/p+, and 
Ube3am+/pYFP mice. Homozygous Ube3aYFP mice were excluded from experiments.
Mice were housed in 12:12 LD and given ad libitum access to food and water prior to perfusion. Ube3aYFP 
reporter mice and their control littermates were collected at P30; all others were 2–5 months old at time of perfu-
sion. Males and females were balanced in number across genotypes. Unless otherwise stated, mice were perfused 
between ZT4–ZT9. At the indicated ZTs, mice were deeply anesthetized with sodium pentobarbital (60 mg/kg, 
i.p.) before being transcardially perfused with room-temperature phosphate-buffered saline (PBS) immediately 
followed by room-temperature phosphate-buffered paraformaldehyde (pH 7.3). Optic nerves were severed prior 
to removing the brains from skulls, and the brains were then placed in fixative overnight at 4 °C. Fixed brains 
were then cryoprotected in 10%, 20%, and 30% sucrose in PBS at 4 °C for 12 hours each. Brains were then frozen 
in dry ice, and coronal sections (40 μ m thick) were collected using a freezing sliding microtome (ThermoFisher 
Scientific, Kalamazoo, MI, USA). Sections were stored in a cryopreservative solution (v/v: 45% PBS, 30% ethylene 
glycol, 25% glycerol) at − 20 °C.
Tissue sections were washed several times in PBS and blocked in PBS containing 5% normal goat serum and 
0.2% Triton X-100 (NGST) for 1 hour at room temperature. Blocked tissue sections were incubated with primary 
antibodies diluted in NGST for 48 hours at 4 °C. Sections were then washed several times in PBS containing 0.2% 
Triton X-100 before incubation with secondary antibodies (diluted in NGST) for 1 hour at room temperature. 
The following primary antibodies were used: mouse anti-UBE3A (1:1,000, clone 3E5, Sigma Cat. #SAB1404508); 
mouse anti-NEUN (1:750, clone A60, Millipore, Billerica, MA, USA, Cat. #MAB377); rabbit anti-SOX2 (1:2,000, 
Active Motif, Carlsbad, CA, USA, Cat. #39823); rabbit anti-VIP (1:2,000, Immunostar, Hudson, WI, USA, Cat. 
#20077); rabbit anti-AVP (1:2,000, Millipore Cat. #AB1565); mouse anti-BMAL1 (1:2,000, Bethyl Laboratories, 
Montgomery, TX, USA, Cat. #A302–616 A); rabbit anti-PER2 (1:5,000, clone R38; Millipore, Cat. #AB2202); 
rabbit Anti-GFAP (1:750, Dako North America, Inc., Carpinteria, CA, USA, Cat. #Z0334); and chicken anti-GFP 
(1:2,000, Aves Labs, Tigard, OR, USA, Cat. #GFP-1020). The following secondary antibodies from Invitrogen 
(Carlsbad, CA, USA) were used at a 1:500 concentration: goat anti-mouse IgG1 Alexa Fluor 568 (Cat. #A-21124), 
goat anti-mouse IgG2A Alexa Fluor 488 (Cat. #A-21131), goat anti-rabbit Alexa Fluor 568 (Cat. #A-11011), goat 
anti-rabbit Alexa Fluor 633 (Cat. #A-21071), and goat anti-chicken IgY Alexa Fluor 488 (Cat. #A-11039). Where 
specified, sections were incubated for 30 min following secondary antibodies with NeuroTrace 640/660 Deep-Red 
Fluorescent Nissl Stain (ThermoFisher Scientific, Cat. # N21483), diluted 1:200 in PBS, prior to final washes. In all 
experiments, 4′ ,6-diamidino-2-phenylindole (DAPI) was added during the secondary antibody incubation at a 
concentration of 700 ng/ml for nuclear counterstaining and delineation of the boundaries of the SCN. Perfusions, 
tissue sectioning, and immunostaining were performed by experimenters blind to genotype. Brain sections com-
pared within figures were stained within the same experiment under identical conditions.
Confocal Microscopy and Image Analysis. Immunostained sections containing the SCN were imaged 
using a Zeiss LSM 710 confocal microscope equipped with ZEN Imaging Software (Zeiss, Jena, Germany). 
Single-plane optical slices of 1.8 μ m in thickness were acquired using a 20× objective (Plan-Apochromat 20 × /0.8 
M27) at a pixel dwell time of 3.15 μ sec with 4× averaging. Images containing the SCN, the 3rd ventricle and sur-
rounding hypothalamic regions, or the BNST or CeA, were acquired by tiling 3 × 3 micrographs of 1024 × 1024 
pixels that were stitched using ZEN software. Images compared within figures were acquired using identical 
acquisition parameters. All images to be compared underwent identical manipulations for brightness and con-
trast, unless otherwise stated in the figure legends.
Quantification of immunofluorescent signals was performed in ImageJ48 (http://imagej.nih.gov/ij/). We used 
average intensity measurements to address whether changes in UBE3A expression altered protein levels of AVP, 
VIP, and BMAL1, in cell bodies as well as in neuronal processes. We also used a cell-counting approach to exam-
ine the degree of overlap of UBE3A-positive and SOX2-positive, NEUN-positive, VIP-positive, or AVP-positive 
cells in the SCN. To quantify total SCN signal of a given fluorophore, regions bounding the left and right SCN 
were created manually for each image using the DAPI channel, by an experimenter blind to genotype. The regions 
were applied to the channel of interest, and the mean gray values within SCN regions were measured. An oval 
region of a standard size across all images (150 μ m × 300 μ m) was also placed in the adjacent lateral hypothala-
mus beyond the SCN boundaries, and the average intensity within this region was subtracted from the average 
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intensity in the SCN to account for variability in background fluorescence. Intensity measurements in the lateral 
hypothalamus regions (i.e., non-SCN regions) were not different across genotypes or ZTs. Expression measure-
ments of proteins other than UBE3A, whose staining pattern made the genotype evident, were performed blind to 
genotype. To quantify the degree of colocalization, cell bodies positive for each immunofluorescent signal within 
each SCN region (defined by DAPI counterstaining) were manually counted, and the percentage of cells positive 
for both fluorophores was calculated. Sections containing rostral, central, and caudal regions of the SCN were 
imaged for all conditions and included for quantification in a balanced fashion.
Statistical analysis. Statistical analyses were performed using GraphPad Prism version 6.00 for Windows 
(GraphPad Software, La Jolla, CA, USA). Unpaired two-tailed Student’s t tests and one-way ANOVA were used 
where indicated. Data are represented as mean ± s.e.m. (error bars). P values less than 0.05 were considered sta-
tistically significant.
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